title: When should anti-vascular endothelial growth factor treatment be stopped in age-related macular degeneration?
authors.forename: Alain
authors.initials: A
authors.lastname: Gaudric
authors.forename: Salomon Y
authors.initials: SY
authors.lastname: Cohen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A